WallStreetZenWallStreetZen

NASDAQ: GOSS
Gossamer Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Gossamer Bio earnings were -$56.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest GOSS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$33.0M, up 7.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GOSS reported annual earnings of -$56.5M, with -68.6% growth. The next GOSS earnings date is May 5, 2025.

GOSS earnings history

Current Revenue
$114.7M
Current Earnings
-$56.5M
Current Profit Margin
-49.3%

GOSS Return on Equity

Current Company
-117.8%
Current Industry
0.3%
Current Market
33.5%
GOSS's Return on Equity (-117.8%)... subscribe to Premium to read more.
High Return on Equity Performance

GOSS undefined

Current Company
-17.4%
Current Industry
0.9%
GOSS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GOSS announces earnings.

GOSS undefined

Current Company
-16.32%
Current Industry
8%
GOSS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GOSS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GOSS-$39.97M-$56.53MN/A-$0.25
RGNX-$198.23M-$227.10MN/A-$4.59
AMLX-$301.23M-$301.74MN/A-$4.43
CMPX-$47.62M-$49.38MN/A-$0.36
ZBIO-$155.74M-$156.99MN/A-$11.89
View Top Biotech Stocks

GOSS earnings dates

Next earnings date
May 5, 2025

Gossamer Bio Earnings Reports & History FAQ

What were Gossamer Bio's earnings last quarter?

On GOSS's earnings call on Invalid Date, Gossamer Bio (NASDAQ: GOSS) reported Q4 2024 earnings per share (EPS) of -$0.15, up 0% year over year. Total GOSS earnings for the quarter were -$33.03 million. In the same quarter last year, Gossamer Bio's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Gossamer Bio stock.

When does Gossamer Bio report earnings?

The next GOSS earnings call is Invalid Date. Add GOSS to your watchlist to be reminded of Gossamer Bio's next earnings date.

Is Gossamer Bio profitable or losing money?

As of the last Gossamer Bio earnings report, Gossamer Bio is currently losing money. Gossamer Bio's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$56.53 million, a 68.56% decrease year over year.

What was GOSS's earnings growth in the past year?

As of Gossamer Bio's earnings date in Invalid Date, Gossamer Bio's earnings has grown year over year. GOSS earnings in the past year totalled -$56.53 million.

What are Gossamer Bio's earnings expectations?

The current EPS estimate for Gossamer Bio's earnings report in Invalid Date is -$0.19.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.